Back to Trades
Perriman Damien Alan
Chief Commercial OfficerCIK 0002096714
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2026
Perriman Damien Alan, Chief Commercial Officer, has filed 5 SEC reports (2026), all concentrated in EXOZYMES INC. (EXOZ), totaling $1.5M in disclosed volume. Weighing $0 bought versus $19.4K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Oct 26 | EXOZ EXOZYMES INC. | Perriman Damien Alan | Chief Commercial Officer | Sell | $19.4K |
| Aug 25 | EXOZ EXOZYMES INC. | Perriman Damien Alan | Chief Commercial Officer | Exercise | $0 |
| Apr 8 | EXOZ EXOZYMES INC. | Perriman Damien Alan | Chief Commercial Officer | Other | $0 |
| Apr 8 | EXOZ EXOZYMES INC. | Perriman Damien Alan | Chief Commercial Officer | Grant | $1.4M |
| Apr 8 | EXOZ EXOZYMES INC. | Perriman Damien Alan | Chief Commercial Officer | Grant | $75.0K |
5 filings